150 related articles for article (PubMed ID: 26907552)
41. The evaluation of a mupirocin-based selective medium for the enumeration of bifidobacteria from probiotic animal feed.
Simpson PJ; Fitzgerald GF; Stanton C; Ross RP
J Microbiol Methods; 2004 Apr; 57(1):9-16. PubMed ID: 15003683
[TBL] [Abstract][Full Text] [Related]
42. Biogas Production: Microbiology and Technology.
Schnürer A
Adv Biochem Eng Biotechnol; 2016; 156():195-234. PubMed ID: 27432246
[TBL] [Abstract][Full Text] [Related]
43. Use of D(acid)-, D(bile)-, z(acid)-, and z(bile)-values in evaluating Bifidobacteria with regard to stomach pH and bile salt sensitivity.
Jia L; Shigwedha N; Mwandemele OD
J Food Sci; 2010; 75(1):M14-8. PubMed ID: 20492180
[TBL] [Abstract][Full Text] [Related]
44. Comparison of mupirocin-based media for selective enumeration of bifidobacteria in probiotic supplements.
Bunesova V; Musilova S; Geigerova M; Pechar R; Rada V
J Microbiol Methods; 2015 Feb; 109():106-9. PubMed ID: 25542994
[TBL] [Abstract][Full Text] [Related]
45. Effect of storage temperature and media composition on the survivability of Bifidobacterium breve NCIMB 702257 in a malt hydrolisate.
Rozada R; Vázquez JA; Charalampopoulos D; Thomas K; Pandiella SS
Int J Food Microbiol; 2009 Jul; 133(1-2):14-21. PubMed ID: 19539389
[TBL] [Abstract][Full Text] [Related]
46. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria.
Masco L; Huys G; De Brandt E; Temmerman R; Swings J
Int J Food Microbiol; 2005 Jul; 102(2):221-30. PubMed ID: 15992621
[TBL] [Abstract][Full Text] [Related]
47. Comparison of four methods to enumerate probiotic bifidobacteria in a fermented food product.
Lahtinen SJ; Gueimonde M; Ouwehand AC; Reinikainen JP; Salminen SJ
Food Microbiol; 2006 Sep; 23(6):571-7. PubMed ID: 16943053
[TBL] [Abstract][Full Text] [Related]
48. [Fractions of barley spent grain as media for growth of probiotic bacteria].
Novik GI; Wawrzynczyk J; Norrlow O; Szwajcer-Dey E
Mikrobiologiia; 2007; 76(6):902-7. PubMed ID: 18297884
[TBL] [Abstract][Full Text] [Related]
49. Any benefits of probiotics in allergic disorders?
Ozdemir O
Allergy Asthma Proc; 2010; 31(2):103-11. PubMed ID: 20406592
[TBL] [Abstract][Full Text] [Related]
50. Methods for quantification of growth and productivity in anaerobic microbiology and biotechnology.
Mauerhofer LM; Pappenreiter P; Paulik C; Seifert AH; Bernacchi S; Rittmann SKR
Folia Microbiol (Praha); 2019 May; 64(3):321-360. PubMed ID: 30446943
[TBL] [Abstract][Full Text] [Related]
51. Stationary-phase acid and heat treatments for improvement of the viability of probiotic lactobacilli and bifidobacteria.
Saarela M; Rantala M; Hallamaa K; Nohynek L; Virkajärvi I; Mättö J
J Appl Microbiol; 2004; 96(6):1205-14. PubMed ID: 15139911
[TBL] [Abstract][Full Text] [Related]
52. Bifidobacteria-host interactions--an update on colonisation factors.
Grimm V; Westermann C; Riedel CU
Biomed Res Int; 2014; 2014():960826. PubMed ID: 25295282
[TBL] [Abstract][Full Text] [Related]
53. In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics.
Grimoud J; Durand H; Courtin C; Monsan P; Ouarné F; Theodorou V; Roques C
Anaerobe; 2010 Oct; 16(5):493-500. PubMed ID: 20670686
[TBL] [Abstract][Full Text] [Related]
54. Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine.
Novik G; Savich V
Microbes Infect; 2020; 22(1):8-18. PubMed ID: 31233819
[TBL] [Abstract][Full Text] [Related]
55. Optimization of a Bifidobacterium longum production process.
Kiviharju K; Leisola M; Eerikäinen T
J Biotechnol; 2005 May; 117(3):299-308. PubMed ID: 15862361
[TBL] [Abstract][Full Text] [Related]
56. Tolerance of Bifidobacterium human isolates to bile, acid and oxygen.
Andriantsoanirina V; Allano S; Butel MJ; Aires J
Anaerobe; 2013 Jun; 21():39-42. PubMed ID: 23598280
[TBL] [Abstract][Full Text] [Related]
57. Enrichment of denitrifying glycogen-accumulating organisms in anaerobic/anoxic activated sludge system.
Zeng RJ; Yuan Z; Keller J
Biotechnol Bioeng; 2003 Feb; 81(4):397-404. PubMed ID: 12491525
[TBL] [Abstract][Full Text] [Related]
58. Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches.
Vaughan EE; Heilig HG; Ben-Amor K; de Vos WM
FEMS Microbiol Rev; 2005 Aug; 29(3):477-90. PubMed ID: 16125009
[TBL] [Abstract][Full Text] [Related]
59. [Effect of probiotics and yogurt on colonic microflora in subjects with lactose intolerance].
Zhong Y; Huang CY; He T; Harmsen HM
Wei Sheng Yan Jiu; 2006 Sep; 35(5):587-91. PubMed ID: 17086711
[TBL] [Abstract][Full Text] [Related]
60. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.
Abe F; Muto M; Yaeshima T; Iwatsuki K; Aihara H; Ohashi Y; Fujisawa T
Anaerobe; 2010 Apr; 16(2):131-6. PubMed ID: 19638311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
